Biometric and structural ocular manifestations of Marfan syndrome
- PMID: 28931008
- PMCID: PMC5607136
- DOI: 10.1371/journal.pone.0183370
Biometric and structural ocular manifestations of Marfan syndrome
Abstract
Background: To study biometric and structural ocular manifestations of Marfan syndrome (MFS).
Methods: Observational, retrospective, comparative cohort study in a tertiary referral center on 285 MFS patients and 267 controls. Structural and biometric ocular characteristic were compared.
Results: MFS eyes were longer (axial length 24.25 ± 1.74 mm versus 23.89 ± 1.31 mm, p < 0.001) and had a flatter cornea than control eyes (mean keratometry 41.78 ± 1.80 diopters (D) versus 43.05 ± 1.51 D, p < 0.001). Corneal astigmatism was greater and the central cornea was thinner in MFS eyes (530.14 ± 41.31 μm versus 547.02 ± 39.18 μm, p < 0.001). MFS eyes were more myopic than control eyes (spherical equivalent -2.16 ± 3.75 D versus -1.17 ± 2.58 D, p < 0.001). Visual acuity was reduced (0.13 ± 0.25 logMAR versus 0.05 ± 0.18 logMAR, p < 0.001) and intraocular pressure was lower in MFS eyes (14.6 ± 3.4 mmHg versus 15.1 ± 3.2 mmHg, p = 0.01). Iris transillumination defects (ITD) were significantly more common in MFS eyes (odds ratio for MFS in the presence of ITD, 3.7). Ectopia lentis (EL) was only present in MFS eyes (33.4%). History of retinal detachment was significantly more common in MFS eyes. Glaucoma was equally common in both groups.
Conclusions: ITD and EL are most characteristic findings in MFS. ITD and corneal curvature should be studied as diagnostic criteria for MFS. Visual acuity is reduced in MFS. MFS patients need regular eye exams to identify serious ocular complications.
Conflict of interest statement
Similar articles
-
Ocular manifestations of Marfan syndrome in children and adolescents.Eur J Ophthalmol. 2019 Jan;29(1):38-43. doi: 10.1177/1120672118761333. Epub 2018 Mar 27. Eur J Ophthalmol. 2019. PMID: 29587526
-
A descriptive study of ocular characteristics in Marfan syndrome.Acta Ophthalmol. 2013 Dec;91(8):751-5. doi: 10.1111/aos.12068. Epub 2013 Feb 7. Acta Ophthalmol. 2013. PMID: 23387925
-
Ocular findings in 87 adults with Ghent-1 verified Marfan syndrome.Acta Ophthalmol. 2015 Feb;93(1):46-53. doi: 10.1111/aos.12448. Epub 2014 May 22. Acta Ophthalmol. 2015. PMID: 24853997
-
Refractive Alterations in Marfan Syndrome: A Narrative Review.Medicina (Kaunas). 2025 Feb 1;61(2):250. doi: 10.3390/medicina61020250. Medicina (Kaunas). 2025. PMID: 40005367 Free PMC article. Review.
-
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.Verh K Acad Geneeskd Belg. 2009;71(6):335-71. Verh K Acad Geneeskd Belg. 2009. PMID: 20232788 Review.
Cited by
-
Management Strategies of Ocular Abnormalities in Patients with Marfan Syndrome: Current Perspective.J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):71-77. doi: 10.4103/jovr.jovr_29_18. J Ophthalmic Vis Res. 2019. PMID: 30820290 Free PMC article. Review.
-
What Should We Pay More Attention to Marfan Syndrome Expecting Ectopia Lentis: Incidence and Risk Factors of Retinal Manifestations.J Pers Med. 2023 Feb 24;13(3):398. doi: 10.3390/jpm13030398. J Pers Med. 2023. PMID: 36983580 Free PMC article.
-
Zonular fibre Insertion-to-Limbus Distance (ZLD): normative data to assess lens position and diagnose ectopia lentis.Int Ophthalmol. 2024 Jun 24;44(1):266. doi: 10.1007/s10792-024-03163-0. Int Ophthalmol. 2024. PMID: 38913255 Free PMC article.
-
Developmental abnormalities in the cornea of a mouse model for Marfan syndrome.Exp Eye Res. 2020 May;194:108001. doi: 10.1016/j.exer.2020.108001. Epub 2020 Mar 13. Exp Eye Res. 2020. PMID: 32173378 Free PMC article.
-
Pars plana lensectomy and iris-claw Artisan intraocular lens implantation in patients with Marfan syndrome.Oman J Ophthalmol. 2023 Feb 21;16(1):64-68. doi: 10.4103/ojo.ojo_25_22. eCollection 2023 Jan-Apr. Oman J Ophthalmol. 2023. PMID: 37007247 Free PMC article.
References
-
- Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–9. doi: 10.1038/352337a0 - DOI - PubMed
-
- Dietz HC, Pyeritz RE, Hall BD, Cadle RG, Hamosh A, Schwartz J, et al. The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics. 1991;9(2):355–61. - PubMed
-
- Wheatley HM, Traboulsi EI, Flowers BE, Maumenee IH, Azar D, Pyeritz RE, et al. Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the Marfan syndrome. Arch Ophthalmol. 1995;113(1):103–9. - PubMed
-
- Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81(3):454–66. doi: 10.1086/520125 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical